Log in to save to my catalogue

CLDN6 inhibits breast cancer growth and metastasis through SREBP1-mediated RAS palmitoylation

CLDN6 inhibits breast cancer growth and metastasis through SREBP1-mediated RAS palmitoylation

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4efe1a97eb60427aa817c80b7246b5c7

CLDN6 inhibits breast cancer growth and metastasis through SREBP1-mediated RAS palmitoylation

About this item

Full title

CLDN6 inhibits breast cancer growth and metastasis through SREBP1-mediated RAS palmitoylation

Publisher

England: BioMed Central

Journal title

Cellular & molecular biology letters, 2024-08, Vol.29 (1), p.112-23, Article 112

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Breast cancer (BC) ranks as the third most fatal malignant tumor worldwide, with a strong reliance on fatty acid metabolism. CLDN6, a candidate BC suppressor gene, was previously identified as a regulator of fatty acid biosynthesis; however, the underlying mechanism remains elusive. In this research, we aim to clarify the specific mechanism through...

Alternative Titles

Full title

CLDN6 inhibits breast cancer growth and metastasis through SREBP1-mediated RAS palmitoylation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4efe1a97eb60427aa817c80b7246b5c7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4efe1a97eb60427aa817c80b7246b5c7

Other Identifiers

ISSN

1689-1392,1425-8153

E-ISSN

1689-1392

DOI

10.1186/s11658-024-00629-y

How to access this item